These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12756225)

  • 1. Mice lacking a transcriptional corepressor Tob are predisposed to cancer.
    Yoshida Y; Nakamura T; Komoda M; Satoh H; Suzuki T; Tsuzuku JK; Miyasaka T; Yoshida EH; Umemori H; Kunisaki RK; Tani K; Ishii S; Mori S; Suganuma M; Noda T; Yamamoto T
    Genes Dev; 2003 May; 17(10):1201-6. PubMed ID: 12756225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome-mediated degradation of Tob is pivotal for triggering UV-induced apoptosis.
    Suzuki T; Tsuzuku J; Kawakami K; Miyasaka T; Yamamoto T
    Oncogene; 2009 Jan; 28(3):401-11. PubMed ID: 18850001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
    Tirone F
    J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of subcellular localization of the antiproliferative protein Tob by its nuclear export signal and bipartite nuclear localization signal sequences.
    Maekawa M; Yamamoto T; Nishida E
    Exp Cell Res; 2004 Apr; 295(1):59-65. PubMed ID: 15051490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of anti-proliferative protein Tob with poly(A)-binding protein and inducible poly(A)-binding protein: implication of Tob in translational control.
    Okochi K; Suzuki T; Inoue J; Matsuda S; Yamamoto T
    Genes Cells; 2005 Feb; 10(2):151-63. PubMed ID: 15676026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.
    Yanagie H; Tanabe T; Sumimoto H; Sugiyama H; Matsuda S; Nonaka Y; Ogiwara N; Sasaki K; Tani K; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 May; 63(4):275-86. PubMed ID: 18657378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis.
    Ma W; Stafford LJ; Li D; Luo J; Li X; Ning G; Liu M
    J Cell Biochem; 2007 Apr; 100(6):1376-86. PubMed ID: 17131381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
    Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation of O(6)-methylguanine-DNA-methyltransferase in lung cancer is regulated by p53.
    Lai JC; Cheng YW; Goan YG; Chang JT; Wu TC; Chen CY; Lee H
    DNA Repair (Amst); 2008 Aug; 7(8):1352-63. PubMed ID: 18555750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription.
    James CG; Woods A; Underhill TM; Beier F
    BMC Mol Biol; 2006 Sep; 7():30. PubMed ID: 16984628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo.
    Graham C; Tucker C; Creech J; Favours E; Billups CA; Liu T; Fouladi M; Freeman BB; Stewart CF; Houghton PJ
    Clin Cancer Res; 2006 Jan; 12(1):223-34. PubMed ID: 16397046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways.
    Damo LA; Snyder PW; Franklin DS
    Mol Carcinog; 2005 Feb; 42(2):109-20. PubMed ID: 15584024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tob is a potential marker gene for the basal layer of the epidermis and is stably expressed in human primary keratinocytes.
    Park GT; Seo EY; Lee KM; Lee DY; Yang JM
    Br J Dermatol; 2006 Mar; 154(3):411-8. PubMed ID: 16445768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NIR is a novel INHAT repressor that modulates the transcriptional activity of p53.
    Hublitz P; Kunowska N; Mayer UP; Müller JM; Heyne K; Yin N; Fritzsche C; Poli C; Miguet L; Schupp IW; van Grunsven LA; Potiers N; van Dorsselaer A; Metzger E; Roemer K; Schüle R
    Genes Dev; 2005 Dec; 19(23):2912-24. PubMed ID: 16322561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TOB suppresses breast cancer tumorigenesis.
    O'Malley S; Su H; Zhang T; Ng C; Ge H; Tang CK
    Int J Cancer; 2009 Oct; 125(8):1805-13. PubMed ID: 19569230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell growth- and P53-dependent transcriptional activity of the midkine promoter confers suicide gene expression in tumor cells.
    Yu L; Ugai S; O-Wang J; Namba M; Kadomatsu K; Muramatsu T; Matsubara S; Sakiyama S; Tagawa M
    Oncol Rep; 2003; 10(5):1301-5. PubMed ID: 12883697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.